Drug intelligence / Profile preview

Lenon

Development stage
Unknown
Lead developer
Citi Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Lenon is a branded generic formulation of levofloxacin, a third-generation fluoroquinolone antibiotic developed and manufactured by Citi Pharma. It acts as a broad-spectrum antibacterial agent by inhibiting bacterial DNA gyrase (topoisomerase II) and DNA topoisomerase IV, which are essential enzymes for bacterial DNA replication, transcription, repair, and recombination. By interfering with these processes, Lenon prevents bacterial cell division and leads to bacterial cell death. It is administered orally and is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections.

Brand names
Lenon
Other names
levofloxacinLevofloxacin 250 mgLevofloxacin250 mgLevofloxacin-250 mgLevofloxacin 500 mgLevofloxacin500 mgLevofloxacin-500 mg
02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on Lenon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lenon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call